- Venture-capital investment in the life sciences sector grew to a record rolling annual total of $17.8 billion in the second quarter.
- Covid-19 is accelerating an already growing demand for real estate in the sector.
- “The biotech sector may be the single most attractive subsector within commercial real estate today,” said Spencer Levy, chairman of Americas research and senior economic advisor for CBRE.
All the fundamentals are aligning for the life sciences industry, as Covid-19 accelerates already growing demand for real estate in the sector.
Rents are rising for lab space, vacancies are plunging and research and development, and employment and new development are expanding further, thanks to strong venture capital investment.